[Everything on this website is protected by US copyright: © 2011-2013 Novobiotronics Inc. Nothing on this website may be used without express written permission from Novobiotronics Inc.]
ANTIBIOTIC RESISTANT BACTERIA RESEARCH
CLICK HERE TO JOIN OUR EMAIL LIST TO RECEIVE ALERTS WHEN WE UPDATE OUR WEBSITE WITH NEW DATA F ROM OUR EXPERIMENTS.
NOVOBIOTRONICS DELIVERS MAJOR BLOW AGAINST MRSA!
• NEWS RELEASE • May 2013•
NEW POTENTIAL DRUG-FREE ELECTRONIC TREATMENT FOR ANTIBIOTIC RESISTANT INFECTIONS DISCOVERED BY NOVOBIOTRONICS INC.
Novobiotronics Inc., a nonprofit educational and scientific research company headquartered in upstate New York, has announced a major breakthrough in the fight against dangerous antibiotic resistant strains of bacteria including the ‘superbug’ fatal menace of MRSA, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa, or PS.
Laboratory experiments by Novobiotronics in collaboration with the State University of New York throughout 2011 & 2012, indicate that the new electronic treatment of antibiotic resistant PS and MRSA has both a ‘bacteriostatic’ effect (the growth rate of the deadly strain was tremendously slowed) as well as a bactericidal effect (it kills the bacteria) when used in conjunction with tiny amounts of standard antibiotics to which the deadly organisms are otherwise normally resistant.
According to the US Center for Disease Control and Prevention, nearly 90,000 people die each year in the United States from antibiotic-resistant bacterial infections, more deaths than breast cancer and prostrate cancer combined. MRSA is now “endemic, and even epidemic in many US hospitals”. From 1999 through 2005, MRSA-related hospitalizations more than doubled from 127,036 to 278,203. It appears that more people in the U.S. now die from the mostly hospital-acquired staph infection MRSA than from AIDS. In addition to deadly MRSA outbreaks in communities across the country, of the two million hospital acquired infections each year, 10% are caused by the antibiotic resistant Pseudomonas (PS), which can often lead to life threatening intensive care unit (ICU) pneumonia and other serious medical conditions.
The current mainstream medical treatment of antibiotic resistant bacterial infections has been to use different types of antibiotics in combinations, but many of the newer and more powerful antibiotics have very serious and even dangerous side effects. Doctors even induce some patients into a coma due to the severity of the drug side effects.
Novobiotronics’ new discovery involves the use of a ‘plasma antenna’, a special type of a helium gas filled fluorescent light, which is used to broadcast oscillating pulsed electric fields at the bacteria. These oscillating and pulsing electric fields slow the growth rate of the bacteria tremendously and when used in conjunction with tiny amounts of a standard antibiotic, actually nullify the bacteria’s ability to resist antibiotics and have demonstrated an ability to kill the deadly MRSA and PS bacteria. Novobiotronics’ collaborators from the State University of New York will be presenting their joint findings at the 113th General Meeting of the American Society for Microbiology (ASM) in May of, 2013 in Denver, Colorado.
For further information, please contact:
Please donate any amount you can. Even a few dollars from many people will be of tremendous value in helping us expand our breakthrough research. Click on the DONATE button below and THANK YOU for helping us move forward in this vital work.With your help, we will change the face of research on cancer, antibiotic resistent infections, lyme disease, malaria and much more!
Check back at this website often to see new releases of our experimental data!
CLICK HERE TO JOIN OUR EMAIL LIST TO RECEIVE ALERTS WHEN WE UPDATE OUR WEBSITE WITH NEW DATA F ROM OUR EXPERIMENTS.
Click Here to GO to the Start of our CANCER Research Information
CLICK HERE for the next data release on our experiments with antibiotic resistant bacteria (coming soon!)
